site2cro Logo
site2cro
Connecting Healthcare to Breakthroughs

Trials

Manage and monitor your clinical trial portfolio.

Active Trials

12

Currently running

In Planning

8

Preparation phase

Total Participants

1,240

Across all trials

Completion Rate

94.2%

Average score

Enrollment Progress

Actual vs Target Enrollment

Trial Phase Distribution

Current portfolio breakdown

Trial Portfolio

Cardiovascular Prevention Study

Active
Phase III

Trial ID: TRIAL-001Cardiology

PI: Dr. Michael Rodriguez • Sponsor: CardioTech Pharmaceuticals

Sites

12

Enrolled

245/300

Start Date

1/15/2024

Completion

96.8%

Data Quality

98.5%

Progress

Oncology Immunotherapy Trial

Active
Phase II

Trial ID: TRIAL-002Oncology

PI: Dr. Sarah Chen • Sponsor: ImmunoGen Research

Sites

8

Enrolled

156/200

Start Date

2/1/2024

Completion

94.2%

Data Quality

97.8%

Progress

Diabetes Management Protocol

Recruiting
Phase III

Trial ID: TRIAL-003Endocrinology

PI: Dr. James Wilson • Sponsor: MetaboCare Inc.

Sites

15

Enrolled

189/250

Start Date

3/10/2024

Completion

92.5%

Data Quality

99.1%

Progress

Neurological Disorder Study

Planning
Phase I

Trial ID: TRIAL-004Neurology

PI: Dr. Lisa Thompson • Sponsor: NeuroAdvance Labs

Sites

6

Enrolled

0/150

Start Date

6/1/2024

Completion

0%

Data Quality

0%

Progress